Pharmaceutical

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025

Highlights will include data from non-clinical and real-world patient useBOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a…

9 months ago

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

Episode Highlights a Truly Remarkable Patient Story Spanning 79 Years Video features 79-year-old Norma Coles, believed to be among the…

9 months ago

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting…

9 months ago

MMCAP Infuse Expands Inmar Agreement, Deploying OneRecall® for Smarter Recalls

MMCAP Infuse members gain automated tools to meet DSCSA requirements and safeguard patient safety WINSTON-SALEM, N.C., April 9, 2025 /PRNewswire/…

9 months ago

Biomed 2025, Israel’s Leading Annual Life Science Conference and Exhibition, to Take Place May 20-22, in Tel Aviv

Plenary session includes investment panel featuring global bankers and VCs TEL AVIV, Israel, April 9, 2025 /PRNewswire/ -- Biomed Israel,…

9 months ago

GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and…

9 months ago

GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and…

9 months ago

Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and…

9 months ago

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel…

9 months ago

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects…

9 months ago